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Abstract  
Tendons and ligaments (T/Ls) play key roles in the musculoskeletal system, but they 
are susceptible to traumatic or age-related rupture, leading to severe morbidity as 
well as increased susceptibility to degenerative joint diseases such as osteoarthritis. 
Tissue engineering represents an attractive therapeutic approach to treating T/L 
injury but it is hampered by our poor understanding of the defining characteristics of 
the two tissues. The present study aimed to determine differences in the proteomic 
profile between native T/Ls and tissue engineered (TE) T/L constructs. The canine 
long digital extensor tendon (LDET) and anterior cruciate ligament (ACL) were 
analysed along with 3D TE fibrin-based constructs created from their cells. Native 
tendon and ligament differed in their content of key structural proteins, with the 
ligament being more abundant in fibrocartilaginous proteins. 3D T/L TE constructs 
contained less ECM proteins and had a greater proportion of cellular-associated 
proteins than native tissue, corresponding to their low collagen and high DNA 
content. Constructs were able to recapitulate native T/L tissue characteristics 
particularly with regard to extracellular matrix (ECM) proteins. However 3D T/L TE 
constructs had similar ECM and cellular protein compositions indicating that cell 
source may not be an important factor for T/L tissue engineering. 
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Statement of significance  
Tissue engineering approaches have the potential to provide materials for treatment 
of tendon and ligament injuries. To date, no studies have characterised the proteome 
of engineered tendon or ligament using the increasingly popular 3D fibrin-based 
culture system. In this paper, we report the first proteome profile of 3D tendon and 
ligament TE constructs and have performed a comprehensive proteomic analysis to 
reveal differences between constructs and native tissues.  
1 Introduction  
Tendons and ligaments (T/Ls) are dense connective tissues that play key roles in 
musculoskeletal system. Both tissues have specialised functions required for 
efficient locomotion [1]. T/L injuries are increasingly common in humans, in 
comparative species such as the dog and the horse [2-5] and are caused as result of 
degeneration or trauma/acute tears. There are currently more than 30 million tendon 
injures per year worldwide [6], with 30-50% of these being sports-related [7].  With 
regards to tendon injuries, rotator cuff tears in humans [8] and superficial digital 
flexor tendinopathy in the horse [9] are  the most common. The aethiopathogenesis 
of this tendinopathy is thought to be caused by repetitive micro trauma resulting in 
degenerative changes subsequently leading to injury [1]. The anterior cruciate 
ligament (ACL) is one of the most frequently injured ligaments in humans with 30% 
caused by trauma and 70% due to degenerative and non-contact injuries [10]. Both 
ACL and medial collateral ligament (MCL) injuries account for 95% of all multi-
ligament injuries in the knee joint [11], resulting in significant joint instability and 
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morbidity [12]. Ligament injury can also lead to significant functional impairment in 
athletes resulting in degenerative joint diseases such as osteoarthritis (OA) [13, 14]. 
Severe T/L injuries are presently treated with autografts or allografts, but these are 
associated with complications such as infection [15], disease transmission and graft 
rejection [15, 16], chronic pain [17], decreased muscle strength [18] and donor site 
morbidity [19].  
Tissue engineering offers great potential for the treatment of T/L injury by aiming to 
provide a biological replacement that mimics the structure, function and longevity of 
native tissue [20]. The tissue engineering approach involves the acquisition and 
cultivation of an adequate source of cells, addition of growth inducing stimuli and 
provision of an artificial ECM (scaffold) in which cells can proliferate and differentiate 
enabling new tissue generation [21]. Fibrin is a natural biomaterial which has been 
used for the creation of engineered T/L constructs using variety of cell sources 
including rat and chick tendon fibroblasts [22-25], human bone marrow stem cells 
[26], human adult ACL [27] and tendon cells [28]. To date an understanding of the 
proteins that comprise these tendon and ligament-like structures is unknown. The 
hypotheses of this study were that 1) native tendons and ligaments have different 
structural protein content and that 2) three dimensional (3D) tissue TE constructs 
formed from T/L cells possess the proteome characteristics of the original tissues. 
Therefore, this study aimed to identify the differences between the proteomes of 
native T/L as well as those from engineered T/L 3D constructs. In this study a 
proteomics workflow using a gel-free separation technique with label-free (LF) 
quantification was used to identify differences in protein abundance.  A detailed 
proteomic comparison between native and TE tendons and ligaments has not 
previously been reported. 
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2 Material and Methods  
All chemicals were supplied by Sigma–Aldrich, Dorset, UK unless otherwise stated. 
2.1 Tissue collection and preparation 
ACLs and long digital extensor tendons (LDETs) were harvested immediately after 
euthanasia from five paired cadaveric canine knee joints. The knee joints were from 
skeletally mature Staffordshire bull terrier dogs (2-5 years old) with a healthy body 
score (4-5/9). The joints were assessed as disease-free by gross inspection. The 
dogs were euthanased for purposes not related to this study and ethical approval for 
use of the cadaveric material was granted by Veterinary Research Ethics 
Committee, School of Veterinary Science (VREC64). Tissues from the right knee 
joint were used for protein isolation and proteomic analysis of the native tissues. 
Tissues from the left knee joint were used for cell isolation and creation of 
engineered tissues, which were subsequently used for protein extraction and 
proteomic analysis. All samples were snap frozen in liquid nitrogen and stored at       
-80°C until required. 
2.2 Tendon and ligament 3D TE construct formation  
The 3D TE constructs were created using a 3D fibrin-based culture system with 
isolated ACL and LDET cells as described previously [22] with minor modifications 
as detailed in the supplementary method information.  
2.3 Protein extraction  
Native tendon, ligament and harvested T/L constructs samples were freeze dried 
overnight and the dry weight then measured. Approximately 3mg of each lyophilised 
sample was disrupted using a micro-dismembrator (B.Braun Biotech. International, 
Germany). Each sample was digested with 1U/ml chondroitinase ABC in 100mM tris 
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acetate pH 8, containing mini protease inhibitor cocktail with EDTA (Roche, UK) for 6 
hours at 37°C with end-over-end mixing. The supernatant was removed following 
centrifugation at 15000rpm at 4°C for 15 minutes. Tissue was extracted in 500µl 4M 
guanidine hydrochloride (GnHCl), 65mM dithiothreitol, 50mM sodium acetate, pH 5.8 
for 48 hours at 4°C with shaking. The samples were then centrifuged at 15000rpm at 
4°C for 15 minutes and the soluble fraction was removed. The protein concentration 
of each soluble fraction was estimated using a PierceTM 660 nm protein assay 
(Thermo scientific, Hertfordshire, UK) and aliquots analysed by 1D SDS-PAGE gel 
electrophoresis to grossly assess the protein expression profile between samples. 
2.4 In-solution trypsin digestion  
Prior to trypsin digestion the GnHCL soluble fraction was diluted 8-fold with 100 mM 
ammonium bicarbonate and further normalised to the sample that had the lowest 
protein concentration. In-solution tryptic digestion was carried out as described 
previously [29].  
2.5 Liquid chromatography and tandem mass spectrometry 
LC-MS/MS was performed using an Ultimate 3000 nano system (Dionex/Thermo 
Fisher Scientific) coupled online to a Q-Exactive Quadrupole-Orbitrap instrument 
(Thermo-Fischer Scientific) using 10µl aliquots of tryptic peptides equivalent to 93 ng 
protein per sample. Samples were randomised and run on a 1 hour gradient with 30 
min blanks in between runs as detailed in the supplementary methods. 
2.6 Proteomic data analysis  
Mass spectrometry data was analysed for identification of protein composition and 
LF quantification using PEAKS® (Version 6, Bioinformatics Solutions, Waterloo, 
Canada) and ProgenesisQI LC-MS (Waters, Elstree Hertfordshire, UK) software. 
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Mass spectrometry data is available in PRIDE database (http://www.ebi.ac.uk/pride/) 
at the European Bioinformatics Institute under accession number PXD003094. 
To identify the protein composition in each group (native ligament, native tendon, 3D 
ligament and 3D tendon) raw MS/MS data were imported into PEAKS® and searches 
then performed against the Ensembl canine taxonomy 
((http://www.ensembl.org/info/data/ftp/index.html). 
Instrument configuration was set as Orbitrap (Orbi-Orbi) and HCD fragmentation. 
The following parameters were used for the PEAKS® search; parent mass error 
tolerance, 10 ppm; fragment mass error tolerance, 0.1 Da, precursor mass search 
type, monoisotypic; enzyme, trypsin; max missed cleavage, 1; non-specific cleavage, 
1; fixed modification; carbamidomethylation, variable modification; oxidation, 
methionine, hydroxylation, and variable PTMs per peptide, 3. The results were 
filtered on the basis of the following parameters; de-novo average local confidence 
score (ALC) % threshold, 50; protein -10lgP> 20; FDR at peptide spectrum matches, 
1%; and unique peptides > 2. The ensemble protein accessions were input into 
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City, CA, USA) and 
gene symbol with protein description and protein subcellular locations were then 
mapped. Proteins were classified into ECM categories according to the Matrisome 
Project [30, 31]. The remaining proteins were categorised according to UNIPROT 
function description [32]. Gene ontology (GO) and protein network analysis was 
carried out using the String bioinformatics tool, version 10 [33]. LF quantitative 
analysis was performed using ProgenesisQI LC-MS software. Search results in 
PEAKs® were adjusted to 1% FDR, unique peptides > 2 and  ALC > 50% and search 
hits were imported into ProgenesisQI [34].  
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2.7 Biochemical analysis  
The biochemical composition of native T/L tissues or 3D TE T/L constructs (n=5) was 
determined by measuring double stranded DNA, collagen and sulphated 
glycosaminoglycan (sGAG) content using previously described protocols [35-37].  
2.8 Histology and Immunohistochemistry 
Native T/L samples and TE constructs created from isolated cell samples (n=3) were 
fixed in 4% paraformaldehyde for 48 hours, embedded in paraffin wax and 4 µm 
longitudinal sections mounted on polylysine-coated slides. Sections were stained 
with H&E and Alcian blue-periodic acid Schiff stain (AB-PAS) (TCS, Biosciences Ltd, 
Buckingham, UK) [38].    
Immunohistological staining was performed on native T/L tissue for asporin, 
aggrecan, versican and collagen type III on deparaffinised sections. The 
immunohistochemistry procedure and antibodies details are provided in the 
supplementary methods. 
2.9 Transmission electron microscopy  
Transmission electron microscopy (TEM) of T/L 3D TE constructs (n=3) was 
performed following fixation in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer 
(Agar Scientific, Essex, UK) for 8 hours, followed by a second fixation and contrast 
stain with 0.1% osmium tetroxide for 90 minutes. Samples were stained with 8% 
uranyl acetate in 0.69% maleic acid for 90 minutes, dehydrated in ascending ethanol 
concentrations and embedded in epoxy resin (all from TAAB Laboratories Equipment 
Ltd, Berks, UK). Ultrathin cross-sections (60-90 nm) were cut with a Reichert- Jung 
Ultracut ultramicrotome (Leica Microsystems Ltd, Milton Keynes, UK) using a 
diamond knife. Sections were then mounted on 200 mesh copper grids and stained 
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with ‘Reynold’s Lead citrate’ stain (VWR, Leicestershire, UK) for 4 minutes. Images 
were obtained using a Philips EM208S Transmission Electron Microscope at 80kv. 
2.10 Statistical analysis  
Statistical analysis for proteomic LF data sets was performed by ProgenesisQI on all 
detected features using transformed normalised abundances for one-way ANOVA. 
Identification of proteins with two or more peptides, greater than 2 fold abundance 
and with a q value (p-value adjusted to FDR) <0.05 were considered significant. 
Quantitative analysis was initially performed by comparing the four groups of tissue 
samples together. After that pair-wise comparisons were performed between native 
ligament and tendon, native ligament and 3D TE ligament construct, native tendon 
and 3D TE tendon construct, and 3D TE ligament and 3D TE tendon constructs. 
Data sets for biochemical analysis were first assessed for normality using a 
Kolmogorov-Smirnov test (Graphpad Software, Version 6, La Jolla, California). All 
data sets were normal distributed and were analysed using one-way ANOVA with a 
Bonferroni post-hoc test using Graphpad Prism. The significance level was set at 
p<0.05. 
3 Results  
3.1 Engineered 3D tendon and ligament constructs display a loose 
architecture with a high degree of cellularity   
Histological observation of native tendon demonstrated a dense, parallel aligned 
architecture and long elongated cellular morphology, however native ligament had 
less compact collagen fibre alignment and a more rounded cell morphology (Figure 
1A and B). H&E staining of 3D constructs indicated that both tendon and ligament 
constructs had a loose architecture and a high degree of cellularity with a fibroblastic 
www.proteomics-journal.com Page 9 Proteomics 
 
 
This article is protected by copyright. All rights reserved. 
 
 
cellular morphology (Figure 1C and D). The presence of collagen fibrils was 
confirmed using TEM, where close-packed narrow diameter collagen fibrils were 
visible in the extracellular space (Figure 1E and F). Collagen fibrils were also found 
to be located in collagen fibripositors (Figure 1E and F), which are actin rich plasma 
membrane protrusions that mediate collagen fibril organisation in embryonic tendon 
[39]. 
3.2 Matrisomal proteins and gene ontology terms associated with ECM 
organisation were more strongly represented in native tissue than in 
engineered 3D constructs 
An average protein content of (μg/mg dry weight) of 181 was measured for native 
T/L and 284 for 3D T/L constructs. A total of 3569, 3743, 4481 and 5790 peptides 
assigned to 167, 215, 442 and 561 proteins each were identified in native ligament, 
native tendon, 3D ligament and 3D tendon, respectively. Between both native tissues 
and 3D tissues 93 proteins were common, which included several ECM proteins 
such as collagen type I ,III, V,VI,  decorin, biglycan, lumican, tenascin C, fibrillin 1, 
fibulin 1, thrombospondin 1 and cellular proteins such vimentin, ATP synthase and 
actin (Supplementary table  1).  
The native T/L proteome contained 40% and 50% matrisomal proteins respectively, 
with 45% and 53% of proteins locations annotated to extracellular space, (Figure 2B, 
2C). The remainder of the native T/L proteome was associated with cytoplasmic, 
nucleus and plasma membrane locations. In both 3D TE tendon and ligament 
constructs 66.3% of proteins were associated with cytoplasmic location whereas 
22% of proteins were associated with translation and signalling and 13.1% were 
matrisomal proteins (Figure 2D and 2E).  
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STRING protein-protein interaction network analysis and GO in both native T/L 
tissues resulted in connected clusters around ECM proteins and matrisomal 
associated proteins. The principal GO processes for both tendon and ligament 
tissues were identified as ECM organisation (FDR adjusted p-values 1.53-26 and 
3.75e-27 respectively), wound healing (FDR adjusted p-value 1.94e-14 and 1.85-14) 
and collagen fibril organisation (FDR adjusted p-values 2.01e-21and1.19e-13) 
(Supplementary Figure 1A and 1B). Principle ontology for 3D ligament and 3D TE 
tendon constructs involved translational elongation (FDR adjusted p-values 3.71e-65 
and 2.3e-63) and protein targeting to ER (FDR adjusted p-values 9.98e-64, and 1.75e-
65). The strongest predicted protein-protein interaction was between the ribosomal 
proteins (Supplementary Figure 1C and 1D). 
3.3 Quantitative differences in protein composition were observed 
between native tendon and ligament but not between constructs formed 
from either tendon or ligament cells. 
Quantitative LF analysis demonstrated a set of 387 proteins within the four tissue 
types with a fold change > 2 and unique peptides > 2. PCA revealed that native 
ligament and tendon samples were distinctly grouped, whereas 3D tendon and 
tendon did not cluster into discrete groups (Figure 3A). 
Pairwise quantitative comparison between native TL demonstrated that native 
ligament was more abundant in fibrocartilaginous proteins such as collagen type II, 
alpha 1, agreccan and chondroadherin, whilst tendon had more thrombospondin 4, 
asporin and collagen type XII (Figure 4A). No differentially expressed proteins were 
found between 3D TL constructs (Figure 4B). Quantitative differences between 
native tendon and 3D tendon resulted in 321 and 62 proteins being more abundant 
in 3D tendon and native tendon respectively. When native ligament and 3D ligament 
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were compared 301 proteins were more abundant in 3D ligament and 62 proteins 
were more abundant in native ligament (Figure 4C and 4D).  
Observation of abundant proteins in both native tendon and ligament when 
compared to 3D tendon and ligament engineered constructs demonstrated not only 
the presence of significantly more ECM proteins and enzyme enhancers but also 
more blood/plasma proteins in both native tissues. In contrast both 3D TE constructs 
had significantly more cellular proteins (Supplementary Tables 2 and 3). 
3.4 Biochemical analysis confirmed differences in cellular and collagen 
content between native tissues and engineered  
Both 3D T/L constructs demonstrated significantly higher DNA content (10.2 ± 1.5 
mg/ dry weight) indicating a high cellularity of both constructs in comparison to the 
native tissues (3.43 ± 0.7) (Figure 3B). In contrast, the collagen content was 
significantly lower in the constructs (average of 3.2%) compared to the native tissues 
(average of 67.8%) (Figure 3C). Native ligament (15.1 ± 0.7) (Figure 5A) contained 
significantly more sGAG in comparison to the native tendon (8.3± 1.03) where higher 
GAG staining in native ligament (Figure 5B and 5C) was located between collagen 
fascicles, fibre bundles and surrounding cells. Each 3D TE tendon or ligament 
construct contained a comparable sGAG content to the native tissue (Figure 5A). 
Native ligament (15.1± 0.7) was significantly higher sGAG compared to native 
tendon. Only 3D ligament constructs (11.1 ± 0.7) had significantly more sGAG than 
native tendon. No significant differences were found between both 3D TL constructs. 
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3.5 Immunohistochemistry supported differences in the abundance of 
versican between tendon and ligament and further demonstrated an 
altered tissue distribution of type III collagen, aggrecan and asporin. 
Proteomic comparison identified native ligament to be more abundant in collagen 
type III, aggrecan and versican, whilst tendon contained more asporin. These 
findings were supported with immunohistochemical staining. In comparison to 
tendon, collagen type III was differentially distributed in ligament being more 
widespread in ligament substance whilst in tendon it was mainly present between 
collagen fascicles (Figure 5D and 5E). A marked presence of aggrecan (Figure 5F 
and 5G) and versican (Figure 5H and 5I) was noted in ligament between collagen 
fascicles in comparison to tendon. Aggrecan was also localised pericellularly in 
ligament and this could be a key characteristic of ligament cells. Asporin (Figure 5J 
and 5K) was found to be distributed between collagen fascicles and surrounding 
tenocytes in tendon, whilst in the ligament asporin was only localised around 
ligament cells.   
4 DISCUSSION 
In this study we have performed a comprehensive analysis of the proteomic 
composition of native T/L tissue and 3D TE fibrin-based constructs. The results 
support the hypothesis that there are key structural protein differences between 
native T/L and that 3D TE constructs share similar characteristics with native tissues 
particularly with regard to prominent ECM proteins.  
The abundance of more fibrocartilaginous proteins such as collagen type II, 
aggrecan, versican, chondroadherin and hyaluronic acid link protein in native 
ligament (ACL) is most likely to be due to the physical adaptation of the tissue 
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against compressive or shear forces generated during twisting of the ACL as the 
knee joint moves through normal range of motion [40]. The formation of fibrocartilage 
in TLs has been shown to occur in response to compression, primarily in regions 
where they approach or traverse bone [41]. Regional variations in cell morphology 
and glycosaminoglycan content in tendons has been reported [42] as well as in the 
canine ACL suggesting that the ligament is subjected to multiaxial stresses [43]. In 
the present study we did not discriminate between different regions of native 
ligament so the higher levels of fibrocartilaginous proteins may arise from the origin 
and insertion regions of the ACL. Nevertheless sGAG analysis, histological and 
immunohistochemical staining of aggrecan and versican in the ACL mid-substance 
indicates that these proteins are also up-regulated throughout the entire ligament. 
The higher proportion of collagen type III, aggrecan and versican observed in 
ligament agrees with a previous comparison between human ACL and patellar 
tendon [44]. 
In the current study 3D TE constructs were created from mature canine LDET and 
ACL fibroblasts using in-vitro 3D cell fibrin cultures [22]. Constructs from both tissues 
displayed a high degree of cellularity and collagen fibril content. Collagen fibrils were 
mainly located in extracellular space, but were also occasionally found in plasma 
membrane protrusions also known as fibripositors found previously in embryonic 
tendon [39, 45]. The proteomic comparison between native TL tissue and 3D TE 
constructs demonstrated significantly more ECM proteins in native tissues, whilst 
both 3D tissues had more cellular associated proteins. The higher levels of cellular 
associated proteins in 3D TE constructs is likely to be due to the greater cell content 
in these tissues compared to the native tissues. Their high DNA and low collagen 
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content is indicative of a high cell-to-matrix ratio. In contrast 3D TE constructs were 
also found to contain high sGAG content, suggesting that the proteoglycans are 
rapidly acquired and mature much faster or may require less maturation than the 
collagen matrix. Proteoglycans have been shown to play role in regulation of tendon 
collagen fibrillogenesis [46] and prevent later fusion of collagen fibrils [47]. This 
higher proteoglycan content (based on sGAG measurement) might play an important 
role in organisation of the collagen fibrils and development of 3D TE constructs. 
Therefore our findings reflect the immature state of the constructs in this study and 
are consistent with previous observations in adult human tendon constructs [28, 48]. 
To date, the extent of maturation of 3D tissue engineered T/L constructs is not fully 
known. However, Herchenhan et al. [48] demonstrated a 5-fold and 50% increase of 
mechanical strength and collagen fibril diameter when constructs were subjected to 
static tension for 5 weeks. Other studies have identified that factors such as uniaxial 
cyclic stretch [49] and addition of growth factors such as transforming growth factor 1 
or insulin growth factor 1 [23, 27] can increase collagen gene expression, content 
and fibril diameter in 3D fibrin constructs.  
PCA analysis of our proteomic data suggested that there were no statistically 
significant differences between 3D T/L constructs. This was in contrast to native T/L, 
which separated into distinct groups, based upon their protein content. These 
findings suggest that fibroblasts of the T/L do not result in distinct 3D constructs 
during the 14-day culture period we have used. This might indicate that cell source is 
not an important factor for tissue engineering although longer term in vitro studies 
with more mature constructs would be required to test this. Proteomic composition 
between 3D T/L constructs that were derived from T/L cell source indicate that 
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tendon and ligament fibroblasts are not phenotypically distinct when cultured in-vitro. 
This data indicates that fine-tuning ECM composition may be more significant 
challenge for tendon and ligament tissue engineering. It is yet to be determined 
whether T/L cells become a tendon/ligament or whether different cell sources such 
mesenchymal stem cells or skin dermal fibroblasts differentiate into ligament or 
tendon when situated in their native in-vivo environment.  
A possible limitation to this study is the chondroitinase ABC treatment step which 
was included to produce a better protein separation of proteoglycan peptides and to 
facilitate trypsin digestion. The extreme charge density of the long GAG chains could 
have interfered with protein separation during ion exchange chromatography and 
could have reduced the efficiency of trypsin digestion, or introduced unwanted 
variability at this crucial step. However the chondroitinase treatment could have also 
extracted other chondroitinase sulphate binding proteins that may have been 
overlooked. It should also be considered that whilst most proteins were solubilised in 
all samples, a fraction of proteins were insoluble and retained in pellet form. This is 
most likely due to cross-linked collagen chains (Peffers et al. 2014). Future studies 
may involve optimisation of protein extraction using a combination of other 
chaotropic agents and LC-MS/MS analysis on the insoluble fraction.  
In conclusion we have shown for the first time the differences between tendon, 
ligament and 3D TE tendon and ligament constructs.  Our findings make a vital 
contribution to future tendon and ligament tissue engineering and regeneration 
strategies.  
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Figure Legends 
Figure 1. Ultrastructural images of native T/L and 3D TE constructs. H&E staining of 
native ligament (A), native tendon (B), 3D ligament constructs (C) and 3D tendon 
construct (D) (Bar 100µm). TEM of 3D TE tendon (E) and ligament (F) constructs 
indicate the presence of aligned extracellular collagen fibrils and fibripositors (black 
arrows) demonstrating that constructs have formed correctly.  
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Figure 2. Protein composition of native T/Ls and 3D TE construct identified with 
PEAKS®. The total number of proteins identified following mass spectrometry in each 
tissue type as well as common proteins between the tissue types is presented (A). 
The proteomes of native tendon (B), ligament (C), 3D tendon (D) and 3D ligament 
(E) constructs were subdivided based on Uniprot function and matrisomal 
classification (Matrisome Project). The associated subcellular locations of the 
proteins are also shown (B-E). 
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Figure 3. PCA and biochemical composition comparison between native tissues and 
3D TE constructs. PCA (A) between native tendon, ligament and 3D TE constructs 
and a comparison of DNA (B) and collagen content (C) (% of dry weight) between 
native tissues and 3D constructs is shown. Values are mean and error bars 
represent standard error of mean (SEM). * indicates p<0.05.   
 
  
www.proteomics-journal.com Page 26 Proteomics 
 
 
This article is protected by copyright. All rights reserved. 
 
 
Figure 4. Label-free proteomic analysis of group comparisons between native tissues 
and 3D TE constructs using ProgenesisQI software. Volcano plots demonstrate 
proteins that were more abundant and significant (p<0.05) between native ligament 
versus native tendon (A), native ligament vs 3D ligament (C) and native tendon vs 
3D tendon (D). No significant proteins were identified between 3D tendon and 3D 
ligament construct (B) as all protein p-values were greater than 0.05. Abundant 
proteins in panel C and D are highlighted in supplementary table 2 and 3.  
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Figure 5. sGAG content in native tendon, native ligament and 3D TE constructs and 
validation of proteomic results. sGAG content measurement (A) (µg/mg dry weight). 
and Alcian blue-PAS histology staining of native ligament (B) and native tendon (C) 
(Bar 100µm) is demonstrated. Immunohistochemistry staining of native ligament and 
tendon for collagen type III (D, E), aggrecan (F, G) versican (H, I) and asporin (J, K) 
(Bar 100µm). Statistical values represent the mean, error bars represent SEM and * 
indicates p<0.05. 
 
 
